Gilead Sciences, Inc. v. Merck & Co, Inc. et al

Filing 258

ORDER REGARDING TRIAL SCHEDULE. Signed by Judge Beth Labson Freeman on 2/26/2016. (blflc3S, COURT STAFF) (Filed on 2/26/2016)

1
2
3

UNITED STATES DISTRICT COURT

4

NORTHERN DISTRICT OF CALIFORNIA

5

SAN JOSE DIVISION

6
7

GILEAD SCIENCES, INC.,

Case No. 13-cv-04057-BLF

Plaintiff,
8
v.

ORDER REGARDING TRIAL
SCHEDULE

9
10

MERCK & CO, INC., et al.,
Defendants.

United States District Court
Northern District of California

11
12
13

IT IS HEREBY ORDERED that trial in this matter shall proceed as follows: Jury

14

selection shall commence on March 4, 2016 at 9:00 a.m. Questionnaires will be completed by the

15

jury on that date. Thereafter, commencing on March 7, 2016 at 9:00 a.m., counsel for the parties

16

may conduct oral voir dire of the entire jury panel, limited to 30 minutes for each side. Counsel

17

shall be prepared to present opening statements immediately after the jury is sworn and Plaintiff

18

shall call its witnesses beginning on March 7, 2016.

19

The Court will allow up to 22 hours per side for all phases of the trial, including the jury

20

trial on invalidity and damages and bench trial on equitable issues. Direct and cross-examination

21

time will be tallied by the Court. Jury selection, opening statements, and closing arguments shall

22

not be counted as part of the 22 hour allocation of time. Openings and closings shall be limited as

23

stated on the record at the pretrial conference on February 25, 2016.

24
25
26
27
28

IT IS SO ORDERED.
Dated: February 26, 2016
______________________________________
BETH LABSON FREEMAN
United States District Judge